Back

YPrime’s Commitment to the UN Global CompactA Letter From Our CEO, Jim Corrigan

A YPrime Blog By:

Jim Corrigan,
Chief Executive Officer, YPrime

YPrime’s Commitment to the UN Global Compact

YPrime’s Commitment to the UN Global Compact

A Letter From Our CEO, Jim Corrigan

A Letter From Our CEO, Jim Corrigan

I am pleased to announce that YPrime has formally committed to the United Nations (UN) Global Compact, marking a significant milestone in our journey toward sustainable and responsible business practices. By endorsing the UN Global Compact’s Ten Principles, we are reinforcing our dedication to making life better for patients and clinicians through innovative technology solutions.

At YPrime, our commitment to solving for certainty extends beyond simplifying clinical trials to addressing crucial global challenges. The Ten Principles of the UN Global Compact, spanning human rights, labor, environment, and anti-corruption, resonate deeply with our values. As a company at the forefront of clinical trial technology, we understand that sustainable development and ethical business practices are essential to fulfilling our vision of advancing science and health.

Our participation in the UN Global Compact strengthens our existing sustainability initiatives and provides a framework for integrating environmental, social, and governance (ESG) principles throughout our operations. Key focus areas include enhancing diversity and inclusion, implementing sustainable practices, maintaining rigorous compliance programs, and expanding access to clinical trials through innovative technology solutions.

We understand that joining the UN Global Compact is just the beginning. YPrime is committed to transparent reporting of our progress and continuous improvement in implementing these principles throughout our organization.

As we move forward, we will actively participate in the UN Global Compact’s action platforms and collaborate with other participants to share best practices and contribute to collective action. We believe that by working together, we can create meaningful change while improving patient outcomes through simplified clinical trials.

Together with our employees, partners, and stakeholders, we will work diligently to uphold these principles while continuing to solve for certainty in clinical research technology that improves lives worldwide. We look forward to sharing our progress and achievements as we embark on this next chapter.

Sincerely,

Jim Corrigan
Chief Executive Officer
YPrime

Scroll to Top